Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sirolimus for solid organ transplantation in children.

Puneet Gupta1, Stuart Kaufman, Thomas M Fishbein

  • 1Georgetown University Hospital, Transplant Institute, Washington, DC 20007, USA. pg63@gunet.georgetown.edu

Pediatric Transplantation
|May 25, 2005
PubMed
Summary

Sirolimus is a key immunosuppressant in solid organ transplantation, showing good graft outcomes. This review focuses on its established role and accumulating data in pediatric transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of vedolizumab in pediatric intestinal transplant rejection.

Intestinal Failure (New York, N.Y.)·2026
Same author

Unveiling the Potential of <i>p</i>-Block Bismuth in Homogeneous Electrocatalytic Proton Reduction: Secondary Coordination Sphere Control of Catalytic Activity.

Journal of the American Chemical Society·2026
Same author

Clay pots for reducing fluoride concentration in drinking water.

The Indian journal of medical research·2026
Same author

Integrative Genomic and Clinical Profiling of Colorectal Cancer Liver Metastases to Guide Personalized Surgery and Liver Transplantation.

Cancer genomics & proteomics·2026
Same author

Invasive Spinal Neuromodulation for Chronic Pain in Pediatric Patients: A Scoping Review.

Pain practice : the official journal of World Institute of Pain·2026
Same author

Data-driven risk stratification and zonal classification of postoperative fluid collections after pancreaticoduodenectomy.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pediatric Nephrology

Background:

  • Sirolimus is a significant immunosuppressive agent in solid organ transplantation.
  • It is utilized for managing acute and chronic rejection and as primary immunosuppression.
  • Initial research focused on adult populations, but pediatric data is now substantial.

Purpose of the Study:

  • To review the current applications and efficacy of sirolimus in pediatric solid organ transplantation.
  • To consolidate existing data on sirolimus use in children undergoing transplantation.
  • To highlight the role of sirolimus in improving graft outcomes in pediatric recipients.

Main Methods:

  • Literature review of studies involving sirolimus in pediatric solid organ transplantation.

Related Experiment Videos

  • Analysis of accumulated data on sirolimus's role in pediatric recipients.
  • Synthesis of evidence regarding efficacy and safety in children.

    • Main Results:

    • Sirolimus demonstrates effectiveness as a rescue agent for rejection in pediatric transplant recipients.
    • It contributes to good graft outcomes when used for primary immunosuppression in children.
    • Growing evidence supports its established role in pediatric transplantation.

    Conclusions:

    • Sirolimus is a valuable immunosuppressive therapy in pediatric solid organ transplantation.
    • The drug is effective in managing rejection and ensuring favorable graft outcomes in pediatric patients.
    • This review underscores the importance of sirolimus in the current pediatric transplantation landscape.